PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 16, 2026Value in Health Regional Issues0 citationsOpen Access

External Reference Pricing Policy of Pharmaceutical Products in Saudi Arabia: Policy Development and Methodological Considerations

View Full Paper
FHF. HussainSaudi Arabian Monetary AuthorityMAMona A. AlmaghrabiSaudi Arabian Monetary AuthorityMAMohammed Al-OwairdhiSaudi Arabian Monetary Authority

Key Points

  • This research aims to analyze the effects of revised external reference pricing (ERP) procedures on pharmaceutical outcomes in Saudi Arabia.
  • Revised existing ERP procedures
  • Evaluated outcomes post-implementation
  • Assessed appeals to the Saudi Food and Drug Authority
  • Reduced complexity in ERP procedures
  • Less variability in pricing outcomes
  • Fewer appeals received by the Saudi Food and Drug Authority

Abstract

The revision of the ERP system reduced the complexity of existing procedures. After the implementation of changes, less variability in outcomes was observed, and as a result, Saudi Food and Drug Authority received fewer appeals. The Saudi Arabian experience offers valuable insights for other countries planning to implement or refine ERP procedures. It serves as input for evaluating ERP as a pricing policy and for assessing the impact of policy design on various factors, such as prices and access to medicines.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Hussain et al. (2026) studied this question.

synapsesocial.com/papers/69b79dce8166e15b153aaf54https://doi.org/10.1016/j.vhri.2026.101600
Ask AI
Helpful
Bookmark
Share
View Full Paper